4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 0.3050
+0.0650 (27.08%)
Aug 1, 2025, 4:11 PM AEST
Bally's Market Cap
4DMedical has a market cap or net worth of 141.99 million as of August 1, 2025. Its market cap has decreased by -33.49% in one year.
Market Cap
141.99M
Enterprise Value
130.86M
Revenue
5.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.31
Market Cap Chart
Since August 7, 2020, 4DMedical's market cap has decreased from 420.97M to 141.99M, a decrease of -66.27%. That is a compound annual growth rate of -19.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 141.99M | -28.13% |
| Dec 31, 2024 | 197.57M | -29.31% |
| Dec 29, 2023 | 279.48M | 125.82% |
| Dec 30, 2022 | 123.76M | -68.87% |
| Dec 31, 2021 | 397.56M | -38.21% |
| Dec 31, 2020 | 643.37M | 52.83% |
| Aug 7, 2020 | 420.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.17B |
| Pro Medicus | 33.63B |
| Cochlear | 20.83B |
| Sonic Healthcare | 13.65B |
| Ramsay Health Care | 8.91B |
| Telix Pharmaceuticals | 7.12B |
| Ansell | 4.34B |
| Mesoblast | 3.05B |